Mercaptopurine
An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia.
Year introduced: 2018(1985)
PubMed search builder options
Subheadings:
Tree Number(s): D02.886.489.534, D03.633.100.759.570
MeSH Unique ID: D015122
Registry Number: E7WED276I5
Entry Terms:
- 6-Mercaptopurine
- 6 Mercaptopurine
- 6H-Purine-6-thione, 1,7-dihydro-
- 6-Thiohypoxanthine
- 6 Thiohypoxanthine
- 6-Thiopurine
- 6 Thiopurine
- 1,7-Dihydro-6H-purine-6-thione
- 6-Mercaptopurine Monohydrate
- 6 Mercaptopurine Monohydrate
- Purinethol
- Puri-Nethol
- Purimethol
- Leupurin
- BW 57-323H
- BW 57323H
- BW 57 323H
- Mercaptopurina Wellcome
- Mecaptopurine Anhydrous
Pharmacologic Action: